Terkko Navigator / -/ Feeds / " ( ( Hepacivirus )|( C-hepatiitivirusten kaltaiset virukset )|( C-hepatiittiviruksen kalta"

Diagnostics, Vol. 12, Pages 1524: Highly Specific and Rapid Detection of Hepatitis C Virus Using RT-LAMP-Coupled CRISPR–Cas12 Assay

IJERPH, Vol. 19, Pages 3558: The Impact of Hepatitis C Virus, Metabolic Disturbance, and Unhealthy Behavior on Chronic Kidney Disease: A Secondary Cross-Sectional Analysis

Hepatitis E Virus and rheumatic diseases: what do rheumatologists need to know?

Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane

Hepatitis C Virus Infects and Perturbs Liver Stem Cells

Hepatitis B virus genetic diversity and mutant

Hepatitis C virus core, NS3, NS4B and NS5A are the major immunogenic proteins in humoral immunity in chronic HCV infection.

Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence

Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKK? and TBK1 functions.

Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKK? and TBK1 functions.

Hepatitis C virus NS5A inhibits mixed lineage kinase 3 to block apoptosis.

Hepatitis E Virus Antibodies in Finnish Veterinarians.

Hepatitis C Virus Infection Caused by Infrequent Exposure in China Should Be of Concern.

Hepatitis B virus infections among health professional students in Mwanza city,Tanzania in 2016

Hepatitis C Virus RNA Is Commonly Detectable in Rectal and Nasal Fluids of Patients With High Viremia

Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact

Hepatitis C Virus Incidence in a Cohort in Medication-Assisted Treatment for Opioid Use Disorder in New York City

Hepatitis C Virus (HCV) Care Continuum Outcomes and HCV Community Viral Loads Among Patients in an Opioid Treatment Program

Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants

Hepatitis B Virus preS/S Truncation Mutant rtM204I/sW196* Increases Carcinogenesis through Deregulated HIF1A, MGST2, and TGFbi.

Hepatitis C Virus Screening Among Adolescents Attending a Drug Rehabilitation Center

Hepatitis E virus: Epidemiology, diagnosis, clinical manifestations, and treatment.

Hepatitis B virus infection among people who use drugs in Iran: a systematic review, meta-analysis, and trend analysis

Hepatitis E Virus Infection: Circulation, Molecular Epidemiology, and Impact on Global Health.

Hepatitis C virus infection and its associated factors among prisoners in a Nigerian prison

Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action

Hepatitis B virus Core protein nuclear interactome identifies SRSF10 as a host RNA-binding protein restricting HBV RNA production

Hepatitis B virus detected in paper currencies in a densely populated city of India: A plausible source of horizontal transmission?

Hepatitis B virus pre-S2 deletion (nucleotide 1 to 54) in plasma predicts recurrence of hepatocellular carcinoma after curative surgical resection

Hepatitis C Virus in Pregnancy: Are We Ready for Test and Treat?

Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men

Hepatitis B Virus Core Particles Containing a Conserved Region of the G Protein Combined with Interleukin-35 Protected Mice against Respiratory Syncytial Virus Infection without Vaccine-Enhanced Immunopathology.

Hepatitis C virus resistance to interferon therapy: an alarming situation

Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy.

Hepatitis E Virus in Manure and Its Removal by Psychrophilic anaerobic Biodigestion in Intensive Production Farms, Santa Catarina, Brazil, 2018-2019.

Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication

Hepatitis B virus P protein initiates glycolytic bypass in HBV-related hepatocellular carcinoma via a FOXO3/miRNA-30b-5p/MINPP1 axis

Hepatitis B Virus Elimination in the U.S.: Time to Dismantle Barriers and Implement Solutions

Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: A case report and review of literature.

Hepatitis C virus cascade of care in the general population, in people with diabetes, and in substance use disorder patients

Hepatitis B Virus Reactivation in Gastrointestinal Stromal Tumor Patients Treated With Imatinib

Hepatitis C Virus Infection among HIV-Infected Patients Attending Dessie Referral Hospital, Northeastern Ethiopia

Hepatitis B Virus RNA as Early Predictor for Response to Pegylated Interferon Alpha in HBeAg-Negative Chronic Hepatitis B

Hepatitis B Virus Affected Serum MicroRNA-203a Level in Hepatocellular Carcinoma

Hepatitis D virus and liver transplantation: Indications and outcomes

Hepatitis E virus re-infection accelerates hepatocellular carcinoma development and relapse in a patient with liver cirrhosis: A case report and review of literature

Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report

Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving Chemotherapy

Hepatitis C Virus and Hepatocellular Carcinoma: Pathogenetic Mechanisms and Impact of Direct-Acting Antivirals